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The South African legal framework regulating the research and commercialisation of plant material, or bioprospecting, consists of the National
Environmental Management: Biodiversity Act, 2004, and the Bioprospecting, Access and Beneﬁt Sharing Regulations issued under that Act in
2008, and Section 30 of the Patents Act, 1978, as amended by the Patents Amendment Act, 2005. The international backdrop to this legislation
is the Convention on Biological Diversity, which came into force in 1993.
In October 2010, the Convention on Biological Diversity adopted the Nagoya Protocol, which is intended to be a binding legal instrument on
the subject of access to genetic resources and the fair and equitable sharing of beneﬁts arising from their utilisation. The underlying principles are
that the prior informed consent of communities holding the traditional knowledge must be obtained and that beneﬁts arising from utilisation of that
knowledge must be shared, the arrangements being managed by the State.
This article is a broad discourse on the relevant legislation as seen from the perspective of an intellectual property lawyer, focusing on the most
recent developments, and illustrating its application in cases which have been reported in the press.
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In recent years, the press has reported on cases where ex-
tracts from South African plant materials, which are used by in-
digenous communities as traditional remedies, have been
patented or attempted to be patented (Business Day, 2010;
Mail & Guardian 2010a, 2010b, 2010c). These press reports
have brought to the public eye the tension between the commer-
cialising and patenting of such extracts, as features of our for-
mal economy, and the position of indigenous communities in
relation to the commercialisation of the products derived from
those extracts. In roughly the same time frame, South Africa
has passed legislation regulating bioprospecting and patent ap-
plications for inventions derived from traditional knowledge⁎ Tel.: +41 793487131.
E-mail address: afm@afmyburgh.com.
0254-6299/$ - see front matter © 2011 SAAB. Published by Elsevier B.V. All righ
doi:10.1016/j.sajb.2011.09.003with the object of strengthening the position of indigenous
communities to negotiate commercial benefits arising from
the commercialisation of these products (Biodiversity Act,
2004; Patents Amendment Act, 2005). In a parallel develop-
ment, legislation to protect traditional works as copyright and
other forms of intellectual property is being debated in Parlia-
ment (the Intellectual Property Laws Amendment Bill, No
8 of 2010). In this legislation, the procedures and flow of ben-
efits are, or are to be, undertaken by the State or State-appointed
bodies.
This legislation directly affects the patentability, in South
Africa, of inventions which are derived from South African-
sourced traditional knowledge. On the other hand, the interna-
tionally applied principles of patent law which require novelty
and inventiveness of inventions to qualify for patentability, al-
ready serve to prevent the registration of patents on plant ex-
tracts which make claims derived from traditional knowledge
relating to those plants.ts reserved.
845A.F. Myburgh / South African Journal of Botany 77 (2011) 844–849The author is an attorney who consults on matters relating to
intellectual property law, amongst others the interrelation of the
new rights created and proposed to be created in traditional
knowledge and existing intellectual property law. This article
is a broad discourse on the relevant legislation as seen from
the perspective of an intellectual property lawyer, focusing on
the most recent developments, and illustrating its application
in cases which have been reported in the press.
2. The convention on biological diversity and the adoption
of the Nagoya Protocol
Before dealing with the South African legislation, it is worth
looking at the country's international obligations which gave
rise to it and the latest developments in international law.
The Nagoya Protocol on access to genetic resources and the
fair and equitable sharing of benefits arising from their utilisa-
tion to the convention on biological diversity (“Nagoya Protocol”)
was adopted on 29 October 2010 by the contracting states to the
United Nations Convention on Biological Diversity (“CBD“)
(CBD, 1995; Nagoya Protocol, 2010). By the end of August
2011, it had been ratified by nearly the minimum number of
fifty CBD contracting states needed before it comes into force,
including by South Africa.
The backdrop to the Nagoya Protocol is found in one of
the three main objects of the CBD, namely “fair and equitable
sharing of the benefits arising out of the utilisation of genetic
resources”, as well as in article 15 of the CBD, which recog-
nises “the sovereign rights of States over their natural resources.”
Article 8(j) of the CBD requires contracting states to “respect,
preserve and maintain knowledge, innovations and practices
of indigenous and local communities embodying traditional
lifestyles relevant for the conservation and sustainable use of
biological diversity and promote their wider application with
the approval and involvement of the holders of such knowledge,
innovations and practices and encourage the equitable sharing
of the benefits arising from the utilisation of such knowledge,
innovations and practices”, subject to their national legislation
(CBD, 1995).
The focus of the Nagoya Protocol is on fair and equitable
sharing of the benefits arising from the utilisation of genetic
resources between the member State providing the resources
and the member State acquiring the resources for utilisation.
Benefits arising from the utilisation of genetic resources that
are recognised under local law as being held by indigenous
and local communities, whether those benefits are monetary
or non-monetary, must be shared by mutual agreement in a fair
and equitable way. Under the term “utilisation” is understood
the research of the genetic resources concerned and their appli-
cation and commercialisation in technical applications and de-
rivative products. The quid pro quo is that providing States
have to give transparent, cost-effective and timely access to
its genetic resources (Nagoya Protocol, 2010; Articles 5 and 6).
Being an instrument which is supplementary to the CBD and
therefore approaches the topic from the perspective of the con-
servation and sustainable use of biodiversity, the Nagoya Proto-
col does not require amendments to intellectual propertylegislation. An international position on intellectual property
law relating to traditional knowledge and genetic resources
is being negotiated in 2011 under the auspices of the Intergov-
ernmental Committee on Intellectual Property and Genetic Re-
sources, Traditional Knowledge and Folklore of the World
Intellectual Property Organisation (WIPO) (WIPO, 2011).3. Postulating the case for legislative protection of
traditional knowledge and its challenges
The simple argument in favour of legislative intervention is
that communities which hold traditional knowledge in the use
of plants need protection against the appropriation and use of
their knowledge by outsiders, especially in the form of patent-
ing and commercialisation of the results of that knowledge
(Mukuka, 2010). The scenario which is invariably drawn,
amongst others by a number of NGOs, is one where the commu-
nity and the plant resource are from a developing country and an
outsider from a developed country patents or commercialises a
product derived from the plant and its associated traditional
knowledge without the authorisation or even knowledge of
the originating community. This kind of appropriation is then la-
belled “biopiracy” (Bavikatte et al., 2010; Mayet, 2010).
Traditional knowledge generally does not qualify for protec-
tion under existing intellectual property law legislation because
it is mostly not new or original. By its very nature, traditional
knowledge is knowledge which has been used by members of
indigenous communities over time and in most cases will
even be in the public domain. Therefore, an item of traditional
knowledge will typically not meet the novelty requirements for
patents and designs, just as a traditional work of an indigenous
community (often referred to as “an expression of culture”) will
not meet the originality requirements of copyright. The subject
matter simply does not fit into intellectual property law systems
(Harms, 2009).
If traditional knowledge needs to be protected or its exis-
tence recognised in commerce and in the intellectual property
framework, specific legislation needs to be passed. This legisla-
tion will have to address complex legal challenges. An indige-
nous community is not recognised as a legal person in law. The
absence of such recognition means that it is not an entity with
which a contract can be concluded, and that it will be difficult,
if not impossible, to identify any given community, its mem-
bers and representatives. Even once these problems are
addressed, it cannot be said that the traditional knowledge
which it practises is something which is “held” by it, if “held”
is used in the sense of “owned”, which means that a legal con-
struct has to be devised by legislation under which a duty is
established to seek consent from, and share benefits with, the
community which practises the traditional knowledge. This
problem is exacerbated when the same traditional knowledge
is practised by different communities, as is so often the case.
(Case studies of use of the same plant remedy by different com-
munities for the same and for different purposes can be found in
Van Wyk and Gericke (2000) and in Brendler and Van Wyk
(2008)). Finally, such legislation will only truly be effective if
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which these rights are recognised reciprocally.
4. Legislation: the Biodiversity Act
Legislation requiring prior informed consent from, and benefit
sharing agreements with, communities which contribute to
bioprospecting research already took effect in South Africa in
2006 in terms of the provisions of Chapter 6 of the National
Environmental Management: Biodiversity Act, 2004 (the
“Biodiversity Act”), although the regulations giving effect to
them were only promulgated in 2008 (Biodiversity Act,
2004; Regulations on ABS, 2008). (For ease of reference,
these legislative provisions are referred to together as the “bio-
prospecting provisions”). The bioprospecting provisions were
implemented in compliance with South Africa's obligations
under the CBD and also anticipate the coming into effect of
the Nagoya Protocol. Although the CBD was binding on
South Africa since it became a party to it in 1995, in terms of
the Constitution it only became law in South Africa when
its terms were enacted by legislation passed by Parliament
(Constitution, 1996; Section 231(4)). The bioprospecting legis-
lation has already been the subject of detailed commentary
(Crouch et al., 2008; Wynberg, 2009).
The original bioprospecting provisions were subject to much
criticism, especially as they required a permit to research. At
the time of initiating the research, the ultimate findings would
be unknown, which in turn made it impossible to determine
the terms of any benefit sharing agreement and therefore to
apply for a permit (Crouch et al., 2008). The situation was
eased by the amendment to the Biodiversity Act by the National
Environmental Laws Amendment Act, 2009, which took effect
from 1 April 2011, in which a distinction was made between
the discovery phase of bioprospecting, which only requires
notification to the Minister, and any resultant commercialisation
phase, which requires a permit.
Under the bioprospecting provisions, prior informed consent
and benefit sharing are regulated by a permit system. A permit
system brings with it State regulation and criminal sanctions.
State regulation may be felt to be appropriate to place an indig-
enous community in a better negotiating position vis-à-vis bio-
prospectors and also enables the problem of how to identify
indigenous communities and their authorised representatives
to be swept under the carpet. However, as appears below, the
bioprospecting provisions also interfere with contractual free-
dom and the patent system. At this juncture, it should be point-
ed out that a permit system and the amendment of intellectual
property legislation are not specific requirements of the
CBD or the Nagoya Protocol - the latter only asks contracting
states to take “legislative, administrative or policy measures,
as appropriate” to achieve its aims (Nagoya Protocol, 2010;
Article 5).
The bioprospecting regulations set out the detail needed for
the application for bioprospecting and export permits and also
contain wide-ranging conditions attaching to their issue. Some
of the items which will cause practical difficulties or result in
legal exposure for applicants are:• Applications may only be submitted by South African per-
sons or companies or by foreign entities jointly with South
African persons or companies (Regulations on ABS, 2008;
Regulation 9). Considering the obligations to which a permit
holder, the South African party in a permit jointly held with
a foreigner will, in reality, take on the brunt of the legal ex-
posure, and it can be expected that bioprospecting transac-
tions will be so structured that only the party in the field
applies for the permit, as opposed to any of the parties higher
up in the commercialisation chain.
• The issue of the permit is the function of the Minister of
Environmental Affairs, who is required to be “satisfied” by
various aspects of the application and is empowered to make
further enquiries in response to an application (Regulations
on ABS, 2008; Regulation 8). The Minister has to be satisfied
with the underlying benefit sharing agreement where tradi-
tional knowledge is being used and may even interfere with
the contractual terms if she considers them not to be fair and
equitable, and intervene in the identification of stakeholders
(Regulations on ABS, 2008; regulation 17). The benefit
sharing agreement may also be published for public comment.
These conditions, as well as the decision making process, can
only result in an extended approval process.
• A benefit sharing agreement has to be in a prescribed form
(Regulations on ABS, 2008; Annexure 8) and, even though
deviations from the form are allowed, it still has to follow its
“general format”, which no doubt includes the clause that it
“constitutes the entire agreement between the parties.” Great
care therefore has to be taken in negotiating and drawing up
the benefit sharing agreement to ensure that all the commercial
terms and contingencies are covered.
• A resolution of the indigenous community consenting to the
benefit sharing agreement and authorising a representative to
enter into it, must be attached to the benefit sharing agreement
(Regulations on ABS, 2008; Annexure 8). Since an indige-
nous community is not a legal person, this resolution, at
best, will only contractually bind the persons who voted in fa-
vour of it. It will not bind community members who were not
at the meeting and those who voted against the resolution. A
majority vote should, however, “satisfy” the Minister, so it
would be prudent to attach an attendance list to the resolution
in which is indicated which attendees voted in favour.
• The permit holder is “liable for the costs of mitigating or
remedying the impact of the bioprospecting on the environ-
ment” (Regulations on ABS, 2008; Regulation 12(f)).
• The consideration due under the benefit sharing agreement is
not paid to the indigenous community, but to the Bioprospect-
ing Trust Fund for the benefit of the community (Regulations
onABS, 2008; Regulation 19; Biodiversity Act, 2004; Section
85(1)). Although the Fund is subject to the Public Finance
Management Act, No 29 of 1999, no audit report had been
issued in respect of it by the Auditor General up the
2009–10 financial year. The handling of money through
this Fund will not only show whether or not indigenous
communities will be satisfied with this arrangement, but
will also indicate the real commercial value of traditional
knowledge in bioprospecting.
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The Biodiversity Act was followed by the 2005 amendment
to the Patents Act, No 57 of 1978, by the Patents Amendment
Act, No 20 of 2005, (the “Patents Act”) and accompanying reg-
ulations, which took effect from 14 December 2007. An appli-
cant for a patent with a complete specification must lodge a
statement stating whether or not the invention for which protec-
tion is claimed is based on or derived from an indigenous bio-
logical resource or genetic resource, as defined in the
Biodiversity Act, or traditional knowledge or use. The purpose
of the amendment, as stated in its preceding Bill, was to “ben-
efit and empower mainly the holders and the practitioners of
genetic or biological resources and indigenous knowledge sys-
tems” and to make it “possible to outlaw bio-piracy activities,
i.e. trafficking in biological materials with a view to developing
patent inventions without prior approval from the relevant au-
thority.” In the case of a positive statement, a copy of the bio-
prospecting permit and other documentation indicating the
relevant community's prior informed consent or benefit sharing
agreement, must also be lodged before the patent can be accept-
ed. An incorrect statement could invalidate the patent (Patents
Amendment Act, 2005).
Turning first to the basic principles relating to the patentabil-
ity of inventions, Section 25 of the Patents Act states that a pat-
ent may be granted for any new invention which involves an
inventive step and which is capable of being used or applied
in trade or industry or agriculture (Patents Act, 1978). The nov-
elty and inventiveness of an invention are adjudicated against
the “state of the art” existing on the date of filing the patent.
It comprises anything which has been made available to the
public, such as existing products, processes or information
about them, and whether it has been made available in South
Africa or anywhere else. The standard of novelty is absolute,
which means that if the invention has been used or published
anywhere in the world before the filing date of the patent, the
invention will be unpatentable for lack of novelty. The require-
ment of an inventive step is met if the invention is not obvious
to a person skilled in the art, having regard to the state of the art
at the time. These principles are universal and are applied in the
patent laws of all industrialised countries.
In many industrialised countries, the substance of patent appli-
cations is examined for compliance with the requirements of nov-
elty and inventive step. On the other hand, patent applications in
South Africa are not substantively examined. Therefore, if a
South African patent does not meet these requirements, it could
still be registered, but it is then up to third parties to apply for
expungement of the patent by bringing proceedings before the
High Court or the Commissioner of Patents. Needless to say,
this is a very expensive and time-consuming procedure.
However, if a South African patentee wishes to extend his
patent to other countries in terms of the international Patent
Cooperation Treaty (“PCT”), of which South Africa is a member,
the patent application will be examined by an accredited interna-
tional searching authority (PCT, 1970). A finding of lack of nov-
elty and inventiveness made through the PCT process will result
in the patent application being withdrawn.It is notable that the South African legislation imposes these
strict requirements on inventions based on indigenous, South
African, sources, but it does not require disclosure of non-
South African sources. On the other hand, Switzerland, Norway
and China have introduced disclosure requirements relating to
genetic resource or traditional knowledge, irrespective of its or-
igin. Germany has the disclosure requirement for the origin of
genetic resources only (Swiss Patents Act of 25 June 1954, as
amended in 2007 — Section 49a; Norwegian Patents Act, Act
1967-12-15 no 09, as last amended in 2009— Section 8b; Chi-
nese Patent Law, as amended in 2009 - Section 25(5); German
Patents Act — Section 34a). It is notable that a failure to dis-
close does not lead to the invalidity of the patent.
6. The outcome of some patent cases involving
South African traditional knowledge
The case of the CSIR's patent on the P57 extract fromHoodia
gordonii has already been reported and commented upon often,
and it is not intended to repeat the details here. The history of
this case is set out, amongst others, in Indigenous Peoples, Con-
sent and Benefit Sharing, by Rachel Wynberg and well-known
human rights lawyer Roger Chennells (Wynberg and Chennells,
2009). Chennells was the attorney representing the San
community.
Questioning the validity of the CSIR patent placed the
community before a dilemma, as recounted by Wynberg
and Chennells (2009): “Early on in the negotiations, the San
faced a difficult choice. Should they oppose or even chal-
lenge the patent, based on ethical considerations and lack
of novelty … or should they adopt a more practical approach
and actively negotiate a share of the royalties? This was a
critical moral dilemma.”
They refer to a moral dilemma of the San people, for whom
“the sharing of knowledge is a culture-defining attribute … and
basic to their way of life. Traditional knowledge of plants is
viewed as collective and the idea of ‘owning’ life is abhorrent.”
Yet the dilemma in the intellectual property dimension can be
described in the same terms — should the San have negotiated
royalties from the commercialising of a patent which may have
been invalid in the light of the absolute standard of novelty or
the requirement of an inventive step?
The benefit sharing agreement between the CSIR and repre-
sentatives of the San communities was concluded in March
2003, before the bioprospecting provisions of the Biodiversity
Act came into force, therefore entirely on a voluntary basis.
In 2006 and 2007, two further benefit sharing agreements
were signed with distributors of Hoodia products. However,
the commercial partners to the P57 project withdrew and, to
all accounts, these agreements have not yet produced signifi-
cant financial returns for the San (Wynberg and Chennells,
2009).
Patents filed under the European Patent Convention for ex-
tracts from Pelargonium sidoides, amongst others to treat
acute and inflammatory diseases and infections, and from rooi-
bos, Aspalathus linearis, and honeybush, Cyclopia intermedia,
for a variety of cosmetic and therapeutic applications and filed
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and inventiveness. (Unlike in South Africa, patents filed
under the European Patent Convention are examined).
The P.sidoides-based patent filed by German phyto-
pharmaceutical company, Dr. Willmar Schwabe GmbH & Co.
KG (“Schwabe”), was the subject of a judgment by the European
Patent Office's Opposition Division in January 2010, in which
the patent was held to be invalid due to a lack of an inventive
step when compared to prior art in percolation and maceration
techniques identified by one of the three commercial objectors.
However, the objection on the ground of illegality for failure to
comply with the disclosure requirements of the CBD to state
the origin of an invention, was rejected because such a disclosure
was not a ground for the invalidity of a patent (European Patent
Office Opposition Division, 2010; Myburgh, 2010).
Similar results were achieved in other attacks on patents for
extracts from plant material where traditional knowledge was
involved (Robinson, 2010). In the writer's opinion, this demon-
strates that the patent system can deal with those cases where an
outsider attempts to patent plant-based traditional knowledge.
The true problem is one of access to justice. As mentioned ear-
lier, patent cases are expensive and complex, and these cases
have often been brought for indigenous communities by non-
governmental organisations, such as the Declaration of Berne
and Biosafety Africa in the P. sidoides case (Mayet, 2010).
Some developing countries have been more pro-active than
South Africa in defending their plant-based traditional knowl-
edge. The Indian Government has made its Traditional Knowl-
edge Digital Library, which documents Indian traditional
medicine treatments, accessible to various examining patent
offices around the world (TKDL, 2011). Peru's National Com-
mission against Biopiracy has taken this a step further by using
its database records to actively oppose the grant of patents con-
taining Peruvian traditional knowledge (WIPO, 2007).7. Developments in the ministerial approval of benefit
sharing agreements under the bioprospecting regulations
In October 2010, HGH Pharmaceuticals (Pty) Ltd an-
nounced the approval by the Minister of Environmental Affairs
of a bioprospecting and export permit and its underlying benefit
sharing agreement with the San concerning a dietary supple-
ment derived from Sceletium tortuosum under its trade mark
Zembrin™. The product is the subject of a patent application
filed in 2009 by another company (South African patent appli-
cation 2009/02001, PCT application no PCT/IB2010/051133),
which was still pending at the time of writing.
Also in October 2010, Schwabe announced that its South
African supplier, Parceval, had entered into a benefit sharing
agreement with Chief Mavuso representing the Alice communi-
ty in the Xhosa Rharhabe Kingdom, to support a bioprospect-
ing and export permit for Pelargonium (Schwabe 2010).
However, by as late as February 2011, out of 58 biopros-
pecting projects, only two permits had been issued (DEA,
2011). One of them was for Zembrin™ (Engineering News,
2010). Approval of the San's benefit sharing agreements forHoodia and Parceval's agreement for Pelargonium were still
outstanding.
8. Conclusions
Ultimately, the greatest criticism of the legislation is that it
stifles innovation and commercialisation of South African-
sourced indigenous plant material, whilst creating unrealistic
expectations about the benefits and causing the indigenous
communities to change the way they organise themselves in
order to obtain and distribute these benefits (Dewan, 2010;
Wynberg and Chennells, 2009).
It is discouraging that, out of 58 bioprospecting projects
over the period from April 2008 to February 2011, only two
permits have been issued. These delays, as well as the burden-
some procedures involving the exercise by the Minister of her
discretion, bring into question whether the procedure is certain,
clear and transparent, and whether it can be implemented in a
cost effective manner within a reasonable period of time, as re-
quired by article 6 of the Nagoya Protocol.
A long outstanding permit application places the patent ap-
plicant in an invidious position, because he cannot have his pat-
ent issued until such time as the relative benefit sharing
agreement is approved and the permit is issued. The access pro-
visions of the bioprospecting legislation must therefore be im-
proved by lowering the bureaucratic burdens in a way which
will be compliant with the Nagoya Protocol, once it comes
into force.
The provisions of the Patents Act relating to inventions
based on traditional knowledge affect South African and non-
South African inventors alike, but South African inventors are
at a greater disadvantage if they wish to extend their patents in-
ternationally. They will only discourage patenting of inventions
arising from bioprospecting in South Africa, and not interna-
tionally, since the South African legislation does not have
extra-territorial effect and no other industrialised country has
benefit sharing as a condition for a the validity of a patent. In
the writer's opinion, access and benefit sharing legislation
should complement a process which records South Africa's tra-
ditional knowledge and encourages home-grown innovation
from that base.
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